(Q54524230)
Statements
Final results of phase II trial of doxorubicin HCl liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma. (English)
1 reference
D J Straus
M Duvic
K Hymes
A Goy
F J Hernandez-Ilizaliturri
T Feldman
B Wegner
26 November 2013
1 reference